醫渡科技旗下醫渡云為“北京普惠健康保”提供主運營平台
格隆匯7月26日丨在國家促進多層次醫療保障體系建設的政策指引下,普惠性商業健康保險“北京普惠健康保”今日正式發佈。該產品將在基本醫療保險的基礎上,為北京市醫保參保人提供補充保障,有效緩解市民的醫療費用負擔。在北京市有關部門的共同指導和監督下,醫渡科技(2158.HK)旗下醫渡云為“北京普惠健康保”提供主運營平台。 只要是北京醫保在保狀態的參保人,不限健康狀況無需體檢即可投保,每年僅需不到人民幣200元,就能獲得人民幣最高300萬元保額的醫療保障。 醫渡科技董事長、首席執行官兼創始人宮盈盈(如璟)女士表示:“我們非常榮幸能夠參與和支持這款產品的發佈。普惠的保險產品是為大眾提供綠色醫療的重要支撐,也是向實現‘健康中國’戰略邁進的關鍵一步。”

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.